2023
A pilot, randomized, placebo-controlled study of mindfulness meditation in treating insomnia in multiple sclerosis
Guarnaccia J, Njike V, Dutton A, Ayettey R, Treu J, Comerford B, Sinha R. A pilot, randomized, placebo-controlled study of mindfulness meditation in treating insomnia in multiple sclerosis. BMC Neurology 2023, 23: 263. PMID: 37434109, PMCID: PMC10334613, DOI: 10.1186/s12883-023-03309-0.Peer-Reviewed Original ResearchConceptsInsomnia Severity IndexSleep efficiencyQuality of lifeMultiple sclerosisSleep qualitySelf-reported sleep qualityMultiple Sclerosis QualityPlacebo-controlled studyPrimary outcome measureParallel group designConclusionThis pilot studySelf-reported outcomesChronic insomniaOutcome measuresStudy interventionLife InventoryI cohortQuality rating scaleInsomniaCognitive functionWeekly sessionsBeneficial effectsLife measurementsRating ScaleMental health
2016
Neural stress reactivity relates to smoking outcomes and differentiates between mindfulness and cognitive-behavioral treatments
Kober H, Brewer JA, Height KL, Sinha R. Neural stress reactivity relates to smoking outcomes and differentiates between mindfulness and cognitive-behavioral treatments. NeuroImage 2016, 151: 4-13. PMID: 27693614, PMCID: PMC5373945, DOI: 10.1016/j.neuroimage.2016.09.042.Peer-Reviewed Original ResearchConceptsCognitive-behavioral treatmentFunctional magnetic resonance imagingStress reactivityMindfulness-based treatmentsAmerican Lung Association's FreedomUnderstanding of stressPsychological mechanismsMindfulness trainingNegative affectConjunction analysisMid insulaCBT groupStress provocationSmoking outcomesBrain regionsCessation treatmentEfficacy of MTCurrent studyEntire sampleDrug useSmoking cessationImportant implicationsMagnetic resonance imagingMindfulnessInsula